Project Grant K99AG090620
Award Date
12/1/24
Completion Date
11/30/26
Dollars Obligated
$133K
Federal Agency
National Institute on Aging
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Mayo Clinic will provide $520,831 over the period of August 1, 2024 to April 30, 2029 to characterize senescent cell populations in skeletal aging. The primary objectives are to: 1) Conduct a detailed characterization of two distinct subpopulations of p16-positive senescent cells identified in the bone microenvironment - growth-arrested p16+/Ki67-/Bcl-2+ "p16KB" cells and proliferative,...
This federal Project Grant award from the National Institute on Aging (NIA), part of the Aging Research program (CFDA 93.866), provides $461,058 to Mayo Clinic to investigate the impact of senescent microglia on the progression of Alzheimer's disease. The research aims to characterize this subpopulation of senescent immune cells in the brain and evaluate whether removing them can slow or delay the advancement of Alzheimer's disease. This award spans the period from April 2024 to March...
This $1,039,863 National Institutes of Health National Institute on Aging project grant funds research at Harvard Medical School to reverse engineer the process of cellular senescence. The research will use new microscopy techniques to observe cell size changes and correlate protein expression and phosphorylation with senescence markers as cells transition from normal to senescent states in vitro and in vivo in young and aged mice. The same induction-maturation-death lifecycle will be studied...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $508,525 Project Grant (R01AG087387) to Mayo Clinic to investigate the role of adipose senescent cells in cognitive function and Alzheimer's disease progression. This 5-year award, effective August 15, 2024, aims to determine if the aging- or obesity-driven accumulation of senescent cells in adipose tissue contributes to cognitive decline and neurodegeneration, including Alzheimer's...
This $351,750 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Yale University aims to investigate the role of the protein NLRX1 in altering T cell immunity and mitigating age-related changes in the immune system. The 5-year research project will: 1) elucidate the mechanisms by which NLRX1 deficiency affects T cell characteristics associated with immune aging, 2) examine how mitochondrial factors like reactive oxygen species and NAD+ influence...
The National Institutes of Health's National Institute on Aging (NIA) awarded a $513,957 Project Grant (CFDA 93.866 - Aging Research) to the Sloan-Kettering Institute for Cancer Research in New York, NY. The 2-year grant, with a start date of September 1, 2024, aims to determine the effects of aging on lymph node (LN) lymphatic endothelial cells (LECs) and how decreased LEC NF-κB signaling contributes to age-related LN atrophy and reduced immune function. The study will utilize single-cell...
This Project Grant award of $105,952 from the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will support research at Weill Medical College of Cornell University to identify and characterize clonal expansions in aging and aging-related diseases. The key objectives are to: 1) develop tools to identify somatic variants at scale from publicly available data, and 2) apply novel technologies to map genotypes to epigenetic phenotypes in single cells...
This $336,070 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research to define and manipulate gene regulatory networks that control the transition through senescence states in primary human cells. The research will focus on generating transcription factor network models of primary human chondrocytes and hepatic stellate cells undergoing replicative and cytokine-induced...
This Project Grant award of $1,294,013, awarded by the National Institute on Aging (NIA) under CFDA 93.866 Aging Research, supports a randomized clinical trial to investigate how biological mechanisms of aging, such as cellular senescence and epigenetics, impact exercise response variability in older adults.
The Mayo Clinic, the prime awardee, will conduct a 6-month progressive resistance training intervention and a health education control intervention with 300 older adults (≥65 years) to...
This $834,627 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of a novel "theranostic" (therapeutic and diagnostic) chimeric antigen receptor (CAR) T cell platform to target senescent cells associated with Alzheimer's disease.
The key products and services to be delivered under this award include: 1) developing a senescence-responsive theranostic "ABA inducer" probe to detect and report on senescent cells, 2)...